recombinant erythropoietin stimulating protein(3SBio Inc)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant erythropoietin stimulating protein(3SBio Inc)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionErythropoietin release stimulants

TargetsUpdating

Therapy Area/IndicationsRenal Insufficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator Companies3sbio Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies3sbio Inc

Active IndicationsN/A

Inactive IndicationsRenal Insufficiency

ATC CodeN/A